Post by
N0taP00p on Jan 31, 2023 10:12am
The Head, The Heart and The Gut
My head says: This is a Canadian penny stock that's been languishing in the trenches for a dozen plus years. No one knows about this company. There is a lack of management trust. An inability to raise money with decent terms and with the backing of its science and clinical data. They will delay again and make excuses. The longs will explain it away. Groundhog Day every day.
My Heart says: Breakthrough drugs require a lot of toil, trial and errors. If this were in the US, might have been a different story in terms of financing, publicity , opportunities for collaboration, etc. It's going to break to the upside very soon. Bladders Forever, with Rutherrin instead of Vibranium. Waiting to be discovered by the world.
My Gut? My gut says, if they miss this Q1 deadline for whatever reason, I must say Goodbye Forever to 50 percent of my shares and defer to the head, going forward.
Comment by
Rumpl3StiltSkin on Jan 31, 2023 10:20am
Poop, I hear ya. This stock is constantly overlooked cuz it's in Canada, on the Venture X. Yet I think they are just waiting on Clinicians to compile data. I don't think they are waiting until RW is back at the helm, yet that happens middle of next month. I don't think they will miss the Q1 deadline....
Comment by
Rumpl3StiltSkin on Jan 31, 2023 11:44am
TDon, lol. And I always thought you were RW? Lol. For some reason? Anyway, I think He will only have to navigate as far as the JV/Buyout. I think he has those skills, in spades...
Comment by
ScienceFirst on Jan 31, 2023 12:34pm
TLT will put itself on sales after GBM and NSCLC Ph. 1b. It's been clear right before they even started NMIBC Ph. 1b. So far, all this under a shoestring R&D budget and with higher efficacy than any big pharma and biotech has ever been close to deliver over the last 50y. Without the many initiatives of Roger, nothing have happened.